Outsourcing is booming across all platforms, from fill/finish to cell therapies, as companies pursue efficiency, scale, and strategic flexibility.
Yasmin Timol
Advertisement
Articles by Yasmin Timol
Advertisement
Latest Updated Articles
Outsourcing Hits Record Levels for All Bioprocess PlatformsPublished: July 25th 2025 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of FDA’s New Draft Guidance on Innovative Trial Design for Rare-Disease CGTs
2
White House, Pfizer Reach First MFN Pricing Agreement; Who's Next?
3
New FDA Guidance Utilizes Real-World Data and AI for Postmarket CGT Surveillance
4
The Importance of Innovation in Mission-Critical BioPharma Cold Storage
5
